| Title : Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome - Garin_2005_J.Clin.Endocrinol.Metab_90_2264 |
| Author(s) : Garin MC , Kalix B , Morabia A , James RW |
| Ref : J Clinical Endocrinology Metab , 90 :2264 , 2005 |
| Abstract : Garin_2005_J.Clin.Endocrinol.Metab_90_2264 |
| ESTHER : Garin_2005_J.Clin.Endocrinol.Metab_90_2264 |
| PubMedSearch : Garin_2005_J.Clin.Endocrinol.Metab_90_2264 |
| PubMedID: 15687341 |
| Title : Paraoxonase-1 promoter polymorphism C--107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status - James_2005_Pharmacogenet.Genomics_15_441 |
| Author(s) : James RW , Kalix B , Bioletto S , Brulhart-Meynet MC |
| Ref : Pharmacogenet Genomics , 15 :441 , 2005 |
| Abstract : James_2005_Pharmacogenet.Genomics_15_441 |
| ESTHER : James_2005_Pharmacogenet.Genomics_15_441 |
| PubMedSearch : James_2005_Pharmacogenet.Genomics_15_441 |
| PubMedID: 15900219 |
| Title : Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1 - |
| Author(s) : Blatter-Garin MC , Kalix B , De Pree S , James RW |
| Ref : Diabetologia , 46 :593 , 2003 |
| PubMedID: 12739030 |
| Title : The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients - Leviev_2001_Diabetologia_44_1177 |
| Author(s) : Leviev I , Kalix B , Brulhart Meynet MC , James RW |
| Ref : Diabetologia , 44 :1177 , 2001 |
| Abstract : Leviev_2001_Diabetologia_44_1177 |
| ESTHER : Leviev_2001_Diabetologia_44_1177 |
| PubMedSearch : Leviev_2001_Diabetologia_44_1177 |
| PubMedID: 11596674 |